Softox Inhaled Solution (Sis)
Healthy Volunteers, Safety
Phase I
Completed
Safety of Ascending Single and Multiple Doses of Nebulised SoftOx Inhalation Solution in Healthy Subjects
Dec 09, 2021
―
Softox Biofilm Eradicator (Groups 1 To 7), Sterile Isotonic Saline (Groups 1 To 4)
Chronic Leg Ulcer, Venous Leg Ulcer
Phase I
Completed
Safety and Tolerability of Single and Multiple Doses of SoftOx Biofilm Eradicator (SBE) in Chronic Leg Wounds
Oct 18, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does SoftOx Solutions AS (6FV) have in its pipeline
6FV is currently developing the following drugs: Softox Inhaled Solution (Sis), Softox Biofilm Eradicator (Groups 1 To 7), Sterile Isotonic Saline (Groups 1 To 4). These drug candidates are in various stages of clinical development as the company works toward FDA approval.